This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Mar;117(1):114-20.

doi: 10.1016/j.jss.2003.12.005.

COX-2: a target for prevention and treatment of esophageal cancer

Nasser Altorki¹

Affiliations

PMID: 15013721
DOI: 10.1016/j.jss.2003.12.005

Review

COX-2: a target for prevention and treatment of esophageal cancer

Nasser Altorki. J Surg Res. 2004 Mar.

. 2004 Mar;117(1):114-20.

doi: 10.1016/j.jss.2003.12.005.

Author

Nasser Altorki¹

Affiliation

¹ Weill Medical College of Cornell University, New York, New York 10021, USA. nkaltork@med.cornell.edu

PMID: 15013721
DOI: 10.1016/j.jss.2003.12.005

No abstract available

PubMed Disclaimer

Similar articles

[Colorectal cancer and inhibition of cyclooxygenase-2].
Geissler M, Mohr L, Blum HE. Geissler M, et al. Dtsch Med Wochenschr. 2002 Jun 7;127(23):1256-8. doi: 10.1055/s-2002-32104. Dtsch Med Wochenschr. 2002. PMID: 12053285 German. No abstract available.
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA, Dubois RN. Gupta RA, et al. Nat Rev Cancer. 2001 Oct;1(1):11-21. doi: 10.1038/35094017. Nat Rev Cancer. 2001. PMID: 11900248 Review.
Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS, Derksen E, Gaston K. Pruthi RS, et al. J Urol. 2003 Jun;169(6):2352-9. doi: 10.1097/01.ju.0000047364.56051.74. J Urol. 2003. PMID: 12771797 Review.
COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
Saha D, Pyo H, Choy H. Saha D, et al. Am J Clin Oncol. 2003 Aug;26(4):S70-4. doi: 10.1097/01.COC.0000074161.92815.93. Am J Clin Oncol. 2003. PMID: 12902860 Review.
Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
Liao Z, Milas L, Komaki R, Stevens C, Cox JD. Liao Z, et al. Am J Clin Oncol. 2003 Aug;26(4):S85-91. doi: 10.1097/01.COC.0000074307.55019.29. Am J Clin Oncol. 2003. PMID: 12902863 Review.

See all similar articles

Cited by

New insights into the functions of Cox-2 in skin and esophageal malignancies.
Moon H, White AC, Borowsky AD. Moon H, et al. Exp Mol Med. 2020 Apr;52(4):538-547. doi: 10.1038/s12276-020-0412-2. Epub 2020 Apr 1. Exp Mol Med. 2020. PMID: 32235869 Free PMC article. Review.
Association between COX-2 polymorphisms and non-small cell lung cancer susceptibility.
Zhang T, Li J, Xia T, Zhang N, Zhang Y, Zhao J. Zhang T, et al. Int J Clin Exp Pathol. 2015 Mar 1;8(3):3168-73. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26045835 Free PMC article.
COX-2 mRNA expression is significantly increased in acid-exposed compared to nonexposed squamous epithelium in gastroesophageal reflux disease.
Lurje G, Vallbohmer D, Collet PH, Xi H, Baldus SE, Brabender J, Metzger R, Heitmann M, Neiss S, Drebber U, Holscher AH, Schneider PM. Lurje G, et al. J Gastrointest Surg. 2007 Sep;11(9):1105-11. doi: 10.1007/s11605-007-0210-3. Epub 2007 Jul 10. J Gastrointest Surg. 2007. PMID: 17619937
A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas.
Creemers A, Ebbing EA, Pelgrim TC, Lagarde SM, van Etten-Jamaludin FS, van Berge Henegouwen MI, Hulshof MCCM, Krishnadath KK, Meijer SL, Bijlsma MF, van Oijen MGH, van Laarhoven HWM. Creemers A, et al. Sci Rep. 2018 Sep 5;8(1):13281. doi: 10.1038/s41598-018-31548-6. Sci Rep. 2018. PMID: 30185893 Free PMC article.
BPTF cooperates with p50 NF-κB to promote COX-2 expression and tumor cell growth in lung cancer.
Dai M, Hu S, Liu CF, Jiang L, Yu W, Li ZL, Guo W, Tang R, Dong CY, Wu TH, Deng WG. Dai M, et al. Am J Transl Res. 2019 Dec 15;11(12):7398-7409. eCollection 2019. Am J Transl Res. 2019. PMID: 31934287 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program